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A B S T R A C T
Objective: to explore 1) the perception of stable angina (SA) - impact on quality of life (QoL) and current con-
dition related to SA; 2) SA burden - symptoms and frequency of anginal episodes; 3) impairment attributable to
SA - limitations in daily activities and impact on work; 4) characteristics that might aﬀect the patients’ per-
ception.”
Method: a proprietary questionnaire was administered on-line to SA patients selected using a purpose-built
screening program from general population panels collaborating with IQVIA in Italy, Germany, Spain, and the
UK. Exploratory analyses were performed: descriptive statistics on the total sample and diﬀerent stratiﬁcations
(gender, age class, time since diagnosis) were provided; we used Chi-square tests to compare subgroups.
Results: of more than 25,000 subjects who accessed the survey, 268 were eligible and completed the ques-
tionnaire: mean age was 61 years and women accounted for 30%. Despite being treated, about 40% of patients
reported that SA impacted “completely” or “very much” their QoL, 10% rated their condition as “not good”, and
45.1% stated that they felt “Fair”. The majority of patients were still symptomatic and many of them perceived
that SA had a major impact on their working life. Women, younger patients and those with a more recent
diagnosis reported a worse self-assessment of their condition, QoL and symptom burden.
Conclusions: the results of our survey provide new insights on how patients with SA perceived their own health
status and suggest that any patient with SA deserves a more detailed and accurate evaluation by their physicians.
1. Introduction
Stable Angina (SA) is a common condition in patients with coronary
heart disease, with a prevalence of around 2–4% of the general popu-
lation in western European countries. In patients with cardiovascular
disease, angina is a condition that substantially aﬀects quality of life
(QoL) [1,2], which is negatively related to the frequency of anginal
episodes [3,4]. Despite a number of eﬀective pharmacological treat-
ments and the success of interventional cardiology, SA remains a cause
of signiﬁcant disability and impaired QoL for many patients [5]. Since
angina is diﬃcult to assess objectively, clinical decisions are based on
physician evaluated symptom burden [6]: unfortunately, there is often
discordance between physician evaluation of the burden of the disease
with regard to its severity and/or its impact on the quality of life of the
patients [3,5,7,8]. The CADENCE study showed that, in a relevant
number of cases, general practitioners (GPs) consider angina well
controlled even in patients with frequent attacks (≥ 1/week or daily)
[3]. In a cross-sectional observational study, Quintar found that in
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43.3% of patients, angina symptoms were underestimated. Physicians
reported signiﬁcantly less anginal episodes compared to that reported
by the patients; this led to signiﬁcantly less treatment escalation, di-
agnostic testing, hospitalizations and revascularization compared with
more accurately assessed patients [8]. These data suggest a poor con-
cordance between the physician and the patient with regard to the
perception of the impact of the symptoms, both of which can aﬀect
adversely the clinical management and the QoL of the patient. There
are several factors which may inﬂuence the impact of the disease on
patients by physicians. Recently, the BRIDGE study, which was the ﬁrst
part of this project, explored physicians’ perception of SA patients’
needs, the impact of SA on QOL, and SA management. BRIDGE has
involved 659 doctors (cardiologists and GPs) who entered data from
1965 SA eligible patients. The results demonstrated that physicians’
awareness of the limitations in daily activities was greater for recently
diagnosed patients compared with patients with a longer diagnosis,
irrespective of age and Canadian Cardiovascular Society (CCS) angina
class [6]. Although women generally presented a more severe form of
angina than men, physicians did not perceive diﬀerences between the
condition of the two genders, with possible undertreatment of female
patients, who less frequently underwent angiography, percutaneous
coronary intervention (PCI) and coronary artery bypass graft surgery
[6].
We conducted a multinational survey, directly interviewing the
patients, which is the BRIDGE 2: in line with the BRIDGE [6], and as
completion of the previous study, we aimed to explore 1) the perception
of SA (impact on QoL and current condition related to SA); 2) SA
burden (symptoms and frequency of anginal episodes); 3) impairment
attributable to SA (limitations in daily activities and impact on work).
Also, we investigated whether the characteristics of the patients (age,
gender, time since diagnosis, and previous treatment with PCI) may
have an inﬂuence on all these aspects.
2. Methods
2.1. Study patients
The present study was an organized, prospective patient survey
conducted in four European countries (Italy, Germany, Spain, United
Kingdom [UK]), using computer-assisted web interviewing (CAWI), via
a 30-min on-line quantitative proprietary questionnaire. The survey
was conducted by IQVIA from March to May 2019. IQVIA is among the
largest providers of solutions and information for the pharmaceutical
and healthcare sector. IQVIA has a wide experience in reporting the
pharmaceutical market phenomena with validated data comparable
worldwide, and a long experience in real world data studies and in
patient projects [9]. Respondents were part of global market research
panels collaborating with IQVIA, and were invited by email to take part
in the CAWI survey. Patients were eligible if they met inclusion criteria,
investigated through a quantitative structured screening questionnaire
designed to select patients with a diagnosis of angina currently under
treatment. They had to be older than 18, and meet one of the following
criteria to be enrolled in the core part of the study:
a) diagnosis and current treatment of SA
b) diagnosis of acute myocardial infarction (AMI) and/or diagnosis of
coronary or heart disease/ischemia, with current or past SA symp-
toms and with current treatment for SA.
(see Appendix A of Supplementary Materials for the patient screener
with a detailed description of inclusion criteria). If the patients reported
having been diagnosed with either of the above conditions, they were
asked to specify which deﬁnition best described their situation, ac-
cording to the CCS. The CCS scoring system, based on the degree of
limitation that angina symptoms bring to daily activities, includes four
classes, from 1 (less severe) to 4 (most severe) [10]. Fifteen patients
who reported to be in line with the deﬁnition corresponding to the CCS
class 4 were not included in the ﬁnal analyses as we did within the
BRIDGE study [6].
2.2. Questionnaire
Patients fulﬁlling inclusion criteria were enrolled in the survey and
requested to complete the speciﬁc questionnaire. This was sub-divided
into diﬀerent sections. The ﬁrst included collection of demographic
data, SA therapy, working status, previous treatment with PCI, and
questions about the main activities that the patient was able to do (by
him/herself, with someone's help or with complete assistance), or ac-
tivities he/she did not do, or avoided. The second section focused on the
patient experience with the condition, in particular: their perception
about their condition (“Not good”, “Fair”, ”Good”, “Very good”), how
much the SA impacted on QoL (5= “completely”, 4= very much,
3= somewhat, 2= only a little, 1= not at all, with a half-point scoring
system implemented to capture all possible answers) and on the
working activities, the limitations of daily activities induced by the
symptoms. The third section explored the symptoms and the frequency
of the attacks. Finally, the last part of the questionnaire was dedicated
to the relationship of the patient with the physician (see Appendix B of
Supplementary Materials for the full questionnaire).
According to the Code of Conduct of the European Pharmaceutical
Market Research Association (EphMRA), the survey did not require
Clinical Research Ethics Committee or Independent Review Board ap-
proval [11].
2.3. Statistical analysis
The survey collected anonymized data, analyzed in an aggregated
form through descriptive statistics. Data are presented descriptively as
mean and standard deviation (SD) for quantitative variables, or fre-
quencies and percentages for qualitative variables. All patient data
were analyzed for the overall study population, at European Level, and
for diﬀerent groups, stratiﬁed by age (<65 years, ≥65 years), gender,
duration of diagnosis (≤2 years, >2 years) and previous PCI (yes, no),
to explore possible diﬀerences in disease perception and experience.
Because the presence of depression could have an impact on QoL and
health perception, it was decided to perform a sensitivity analysis by
excluding patients who reported having been diagnosed with depres-
sion (Supplementary Materials, Appendix E). To compare subgroups,
Chi-square tests were used, and p-values <0.05 were considered sta-
tistically signiﬁcant. Analyses were performed using SAS software,
Version 9.4.
3. Results
In contrast to clinical studies, the number of invitations for web-
based market research is much larger than the required sample size,
because of the low response rate [6]. In our case 25,890 individuals
were interviewed through the screening questionnaire; 322 (1.2%) re-
fused to participate in the survey and did not send the disclaimer
agreement; one responder was less than 18 years old; 24,026 (92.8%)
did not report a diagnosis of stable angina, AMI, coronary or heart
disease/ischaemia; 527 (2.0%) had been diagnosed with AMI or cor-
onary or heart disease/ischaemia but had no symptoms of angina; 731
patients (2.8%) had received a diagnosis of angina but were not on
treatment or did not remember. Fifteen patients (0.1%), who classiﬁed
themselves according to the deﬁnition corresponding to the CCS class 4,
completed the questionnaire but they were not included in the analysis.
Data from 268 subjects were included in the ﬁnal analysis (47 in Ger-
many, 70 in Spain, 56 in Italy and 95 in UK) (Fig. 1).
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3.1. Patients’ characteristics and diﬀerences among groups
Seventy per cent of the participants were men, with a mean age of
60.8 years and with a slight predominance of patients younger than 65
years (57.5%). 106 patients classiﬁed themselves as CCS class 1
(39.6%), 108 as CCS class 2 (40.3%), and 54 (20.1%) as CCS class 3;
about 30% of patients had a recent diagnosis (<2 years before the
survey) (Table 1). The severity of SA was greater in women compared
to men. Although younger than men, women declared a higher CCS
score; the patients with a less recent diagnosis (≥2 years) were older,
more frequently men, and had a less severe symptom status in terms of
CCS class (see Appendix C of Supplementary Materials). There were 144
patients who previously underwent PCI representing 53.8% of the
participants (Table 1). Within the ﬁnal Cohort, the most common di-
agnosis was angina alone (43.7%), but more than 14% of the patients
reported having been diagnosed for as having all three conditions as per
the inclusion criteria (angina, AMI, and coronary heart disease/
ischaemia) (data not shown). A majority of the patients (67.5%) were
treated for SA with monotherapy, 23.9% with two drugs, and only 8.6%
with more than two therapies. The most frequently reported co-
morbidities were hypertension (54.9%), dyslipidemia (39.2%), and
diabetes (28.4%). Although most patients were not smokers or had quit
smoking, 17.9% of them reported that they were still smokers at the
time of the survey. The majority of patients were overweight or obese
(BMI ≥ 25 kg/m2), with this trend being slightly more pronounced
among men (Table 1).
3.2. SA perception
3.2.1. QoL
Overall, about 40% of patients reported that SA impacted “com-
pletely” or “very much” their QoL (points 3.5–5). With regard to sub-
groups of interest, the proportion of patients who reported only a minor
impact on their QoL was higher among older patients: 16.7% of them
stated that angina had little or no impact (points 1–1.5), compared to
8.4% for the younger group. However, diﬀerences were not statistically
signiﬁcant. Focusing on results by gender, it should be noted that 15.4%
of men declared that angina had “little” or “no impact” (points 1–1.5)
on their QoL, which is signiﬁcantly greater than the 3.8% observed
among women. In addition, the proportion of patients who declared to
be “not at all” or “only a little” impacted by the condition was sig-
niﬁcantly greater among patients with a longer history of the disease
(14.5%% vs. 5.3%). No diﬀerences in terms of impact on QoL emerged
based on previous PCI presence or absence (Fig. 2). Similar trends were
found in the sensitivity analysis (see Appendix E of Supplementary
Materials, Fig. 2s).
3.2.2. Current SA related condition
10.1% of patients rated their condition as being “not good”, and
45.1% stated to feel “Fair” (Fig. 3). Looking at results from stratiﬁed
analyses, older patients reported a more positive perception of the
disease: more than 15% of them deﬁned their condition as being “very
good”, compared to the 6.5% observed among younger patients, these
diﬀerences being statistically signiﬁcant. The proportion of patients
who deﬁned their condition as “fair” or “not good” was 70% among
women, and 50% among men, while less than 4% of women reported
their condition as being “very good”, compared with the 13% observed
among men these diﬀerences being statistically signiﬁcant. A longer
history of angina seemed to induce a more positive perception of the
condition, although results from this analysis were not statistically
signiﬁcant. Finally, no diﬀerences emerged with regard to disease
perception between patients with or without previous PCI. Similar
trends were found in the sensitivity analysis (see Appendix E of Sup-
plementary Materials, Fig. 3s).
Fig. 1. Selection of patients.
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3.3. SA burden
3.3.1. SA symptoms
Overall, chest pain/tightness, fatigue, and shortness of breath were
the most frequently reported eﬀort related-symptoms, with rates of
74.6%, 72% and 67.5%, respectively. In the stratiﬁed analyses, it
emerged that the proportion of patients who reported having atypical
symptoms was signiﬁcantly greater among women. In particular, we
found a statistically signiﬁcant greater prevalence of arm pain, fatigue,
shortness of breath and headache than those observed among men
(Fig. 4). Similar trends were found in the sensitivity analysis (see Ap-
pendix E of Supplementary Materials, Fig. 4s).
3.3.2. Number of angina attacks
Overall, 52.9% of the patients reported at least one angina attack
per month. A statistically signiﬁcant diﬀerence in the distribution of the
number of attacks was observed depending on gender, while no
diﬀerences were observed depending on age, history of disease and
presence or absence of a previous PCI. In particular, the proportion of
patients who reported at least one attack per month was 63.9% and
48.2% for women and men, respectively (Fig. 5). Similar trends were
found in the sensitivity analysis (see Appendix E of Supplementary
Materials, Fig. 5s).
3.4. Impairment attributable to SA
3.4.1. Limitations in daily activities
Overall, the daily activity for which patients perceived the highest
level of limitation was playing sports, with almost 70% of them
avoiding or not performing such activity at all. Stratiﬁed analyses re-
vealed that the proportions of patients who declared avoiding or not
playing sports at all were signiﬁcantly greater among older patients and
those with a longer history of the disease (data not shown). About half
of the patients declared avoiding doing housework, or requiring help to
perform this activity; the stratiﬁed analyses revealed a statistically
signiﬁcant diﬀerence between women and men: although a lower
proportion of women declared avoiding or not doing housework at all,
at the same time, a higher proportion of them needed some help or full
assistance for this activity. Among all daily activities, climbing stairs
was the one for which we observed a higher proportion of patients
performing this activity unaided. No statistically signiﬁcant diﬀerences
emerged from the stratiﬁed analysis, except for the comparison be-
tween older and younger patients: interestingly among younger sub-
jects we found a signiﬁcantly lower proportion of patients who declared
climbing stairs without assistance. 32.6% of females avoid or need as-
sistance in climbing stairs compared to 22.3% of males but it was not
statistically signiﬁcant (Fig. 6). Similar trends were found in the sen-
sitivity analysis (see Appendix E of Supplementary Materials, Fig. 6s).
3.4.2. Impact on working activities
Table 2 reports the working status of the subjects. The majority of
them were retired or unemployed at the time of the survey, while about
40% were currently working (part-time, full-time or self-employed)
(Table 2).
Patients declared a very high limitation on work activities: only
25.1% of them reported that the disease had no impact on their work,
while more than one third had to change job, reduce the amount of
work time, or stop working completely (Fig. 7). In addition, among
patients at work, about 65% declared the requirement to take sick leave
because of the condition, with 24% of them reporting sick leave more
than once a month (data not shown).
4. Discussion
To our knowledge, this is the ﬁrst survey which extensively explores
the patients’ perception of their SA, its burden as reported by the pa-
tients, and patients’ impairment attributable to SA. The study has also
evaluated the factors that contribute to all these aspects, with particular
attention given to the inﬂuence that age, gender, time since diagnosis
and previous treatment with PCI may have. The results have shown that
women, younger patients and patients with a shorter time from diag-
nosis reported a worse perception of SA, along with more frequent and
severe symptoms. Also, a very high limitation on working activities has
been reported by the patients overall.
Patients included in our survey had a mean age of 61 years, which is
lower compared with the mean age reported by previous studies
[3,6–8,12]; this is probably because the selection of patients was made
through web-based interviews. Our patients stated a slightly more se-
vere condition in terms of CCS class compared with that observed in the
BRIDGE study (20% CCS 3 vs 14%), and reported a longer time from
diagnosis (time since diagnosis >10 years 29.9% and 4.3% respec-
tively) [6]. The longer history of disease observed in the present study
may be due to the fact that in surveys where the selection of patients
Table 1
Characteristics of the patients
Patients’ characteristics
Patients. N 268
Gender, n (%)
Men 188 (70.1%)
Women 80 (29.9%)
Age, years, mean (SD) 60.8 (11.6)
Age class, n (%)
<65 years 154 (57.5%)
>= 65 years 114 (42.5%)
CCS classiﬁcation, n (%)
Class 1 106 (39.6%)
Class 2 108 (40.3%)
Class 3 54 (20.1%)
Time since diagnosis, n (%)
< 1 year 32 (11.9%)
1-2 years 43 (16.0%)
3-5 years 69 (25.8%)
6-10 years 44 (16.4%)
>10 years 80 (29.9%)
Previous PCI, n (%) 144 (53.8%)
Previous coronary bypass, n (%) 63 (23.5%)
Smoking status, n (%)
I have never smoked 68 (25.4%)
I used to smoke. but I stopped more than
one year ago
135 (50.4%)
I used to smoke. but I stopped less than
one year ago
17 (6.3%)
I currently smoke traditional cigarettes
/electronic cigarettes
48 (17.9%)
BMI, n (%) Male Female
Underweight (<18.5 kg/m2) 0 (0.00%) 1 (1.25%)
Healthy (>=18.5 - <25 kg/m2) 40 (21.3%) 22 (27.5%)
Overweight (>=25 - 30 kg/m2) 78 (41.5%) 32 (40%)
Obese I (>=30 - 35 kg/m2) 41 (21.8%) 12 (15%)
Obese II (>=35 kg/m2) 26 (13.8%) 11 (13.75%)
Missing 3 (1.6%) 2 (2.5%)
Treatment(s)
Mono therapy 181 (67.5%)
Two therapies 64 (23.9%)
More than two therapies 23 (8.6%)
Comorbidities n (%)
Hypertension 147 (54.9%)
Hypercholesterolemia / Dyslipidemia 105 (39.2%)
Diabetes 76 (28.4%)
Arthritis 67 (25.0%)
Asthma or COPD 60 (22.4%)
Depression 60 (22.4%)
Gastrointestinal disorders 53 (19.8%)
Anxiety 46 (17.2%)
Heart failure 33 (12.3%)
Osteoporosis 28 (10.4%)
Cancer 26 (9.7%)
Chronic bronchitis 24 (9.0%)
Kidney disease 17 (6.3%)
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was performed by doctors, they probably tend to report data from
subjects with a more recent diagnosis.
The severity of SA was greater in women compared to men: al-
though younger than men, women reported a greater CCS score, a
greater frequency of symptoms, and had a greater number of attacks.
Consistently, most did not have a positive perception of their condition,
and the percentage of women reporting a signiﬁcant impact on QoL was
greater than among men. Our results are consistent with those found in
other studies [3,13–15]. The CADENCE survey recorded a greater fre-
quency of the angina attacks (≥ 1/week) in women, and a direct
relationship between the number of attacks and QoL, assessed with a
speciﬁc validated questionnaire [3,13]; also Dryer reported that women
suﬀered signiﬁcantly more angina attacks, with a poorer QoL as as-
sessed by the Seattle Angina Questionnaire (SAQ) [14]; a higher impact
of the disease on women is possibly caused by less aggressive phar-
macological therapy and less revascularization observed in female pa-
tients [15,16]. In addition, women with coronary heart disease are less
likely to achieve therapeutic targets in the management of risk factors
such as dyslipidemia, diabetes and obesity, and tend to be less physi-
cally active [17–19].
Fig. 2. Impact of “angina or chest pain” on patients’ quality of life, for overall population and subgroups by age, gender, time since diagnosis and previous treatment
with PCI. *Statistically signiﬁcant diﬀerence between the groups (p-value < 0.05).
Fig. 3. Deﬁnition of the current condition of angina or chest pain for the overall population and for subgroups stratiﬁed by age, gender, time since diagnosis and
previous treatment with PCI. *Statistically signiﬁcant diﬀerence between the groups (p-value < 0.05).
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The survey found a greater impact of SA in younger patients, who,
when compared with older ones, reported more symptoms and anginal
episodes, as well as a worse perception of their condition, with a higher
impact of SA on QoL. The greater impairment of QoL perceived by
younger patients may be partly due to more severe angina. Also, coping
with limitations imposed by the condition may be more diﬃcult for
younger people, who generally have a more active life. It has been
previously reported that the elderly may be better able to control their
emotions by minimizing negative emotions and maximizing positive
emotions more eﬀectively than younger individuals [13]. These ﬁnd-
ings are similar to those recorded in other surveys [3,13,20]; in parti-
cular, in the CADENCE study, elderly and very old patients reported a
better QoL and more frequently achieved treatment targets than
younger patients, despite similar disease characteristics and greater
physical limitations [13].
Patients with a more remote diagnosis were older, more frequently
men, and had less severe symptoms with respect to their self-assessed
CCS class than patients with a more recent diagnosis. Consistently,
among patients with a more recent diagnosis higher proportions of
symptoms were observed, almost half of them declared that the SA
impacted “completely” or “very much” on their QoL and, only one-third
of them deﬁned their condition as “good” or “very good”. Also in this
case, the greater severity of the SA could partially account for these
results, but we can also speculate that patients with a longer history of
illness become resigned to their SA and limit and/or avoid some of their
daily activities because they tend to restrict their comfort zone.
Fig. 4. Symptoms occurring during activities such as climbing stairs, walking, dressing, showering or running in the overall population and stratiﬁed by gender.
*Statistically signiﬁcant diﬀerences between the groups (p-value < 0.05).
Fig. 5. Number of attacks per month reported by the overall population and by subgroups stratiﬁed by age, gender, time since diagnosis and previous treatment with
PCI. *Statistically signiﬁcant diﬀerences between the groups (p-value < 0.05).
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In addition, it is worth remembering that within Maslow's Hierarchy
of Needs, for human beings the feelings of safety rank second, after
physiological requirements (food, water, shelter) [21]. This powerful
need is a strong reason for reducing or avoiding activities and situations
which might lead to symptoms or SA attacks and a reduction of the
comfort zone.
Our data conﬁrm the high impact of SA on working life: many pa-
tients had to quit working or to reduce working time; in addition,
among patients who were still working, the disease results in a sig-
niﬁcant amount of sick leave. This phenomenon, as reported by pre-
vious studies, can be caused by a variety of factors, such as patient
characteristics, type of job, and the severity of the symptoms [22,23].
Overall health-related QoL is deﬁned as a multidimensional model
integrating biological and psychological aspects [24,25], and patient's
perception of their own condition is an important independent con-
tributor to QoL in angina [26], and generally in chronic diseases [27].
These factors must be taken into consideration as they are not always
concordant with the perception of the physicians, and therefore can
impact on treatment and clinical outcomes. This is particularly true
since angina cannot be objectively assessed, and appropriate clinical
Fig. 6. Limitations in main daily activities, overall population and groups stratiﬁed by age, gender, time since diagnosis and previous treatment with PCI.
*Statistically signiﬁcant diﬀerences between the groups (p-value < 0.05).
Table 2
SA patients working status.
Total
(N=268)
Working status Full-time employee 57 (21.27%)
Part-time employee 25 (9.33%)
Self-employed 19 (7.09%)
Retired 142 (52.99%)
Unemployed 20 (7.46%)
Prefer not to answer 5 (1.87%)
Fig. 7. Impact of angina/chest pain on working activity.
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decisions are largely guided by a physician's recognition and judgment
of symptom burden [6].
Another interesting ﬁnding of this survey is that, although all pa-
tients were on treatment for SA, many of them were still symptomatic,
40% declared to be impacted “completely” or “very much” by the
disease, and half of them judged their general condition as being “not
good”. This underlines the needs for better understanding and better
management of the patient, particularly in women and in younger and
more recently diagnosed patients.
Our study has some limitations. First, the selection of patients was
possibly inﬂuenced by the ability to access the web and the familiarity
with web navigation, which is observed more often in younger subjects
[20]. This factor could have led to an unusual SA population in terms of
age, working status and condition severity. Second, our direct recruit-
ment through panels, and not through a selection made by physicians,
did not allow speciﬁc and precise clinical details to be obtained.
Nevertheless, our survey was not made to characterize the condition
epidemiologically but to give an insight into patients' perception of
their angina. In addition, the younger age of the population and the
slightly greater severity of the symptoms observed do not seem to have
inﬂuenced the results. In fact, the consistency of our data with similar
studies support our results as reliable and representative of the real-life
population over diﬀerent European countries. Moreover, the direct re-
cruitment of SA patients through panels, can be considered as an ad-
vantage, in as much as the survey avoided some potential biases such as
physicians recruiting patients that they see more and patients they
believe to be more cooperative. Also, the adoption of an ad-hoc
screener which implies rigorous inclusion criteria, allowed completely
objective patient selection. The method used permitted exploration of
issues such as workers vs non-workers and younger vs older patients,
which are not usually evaluated studies of SA.
5. Conclusions
This study, and the previously conducted BRIDGE study [6] have
been complementary projects related to angina management, which
have allowed the exploration of diﬀerent perspectives from the physi-
cian and the patient.
The results of our survey provide new insights on how patients
suﬀering from SA perceive their own health status, revealing that
women, younger patients and patients with a more recent diagnosis
report a worse self-assessment of their condition, their QoL and
symptom burdens. Thus, our survey supports the results of the BRIDGE
study [6], and extend its ﬁndings showing that SA patients develop a
form of tolerance to their condition over time, limiting their activities,
concealing the extent of their disability and therefore restricting their
comfort zone [21]. For the above reasons our data would suggest that
any patient with SA deserves a more detailed and accurate evaluation
by their physicians.
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